If you need more lookups,
subscriptions start at $34 USD/month.
Sergey Yurasov Location
San Francisco, CA, US
Sergey Yurasov Work
Chief Medical Officer @ (June 2022 - Present)
Chief Medical Officer @ (September 2019 - February 2022)
Chief Medical Officer, Senior Vice President @ Immune Design (acquired by Merck) (October 2016 - July 2019)
Senior Vice President, Clinical Development @ (March 2016 - September 2016)
Vice President, Clinical Development @ (September 2014 - February 2016)
Consultant @ (October 2007 - September 2014)
Attending physician @ (March 2005 - October 2007)
Associate Vice President, Global Medical Science @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (February 2013 - August 2014)
Senior Medical Director @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (September 2010 - January 2013)
Senior Associate Medical Director, Early Development, Oncology @ (January 2010 - September 2010)
Associate Medical Director, Oncology @ (August 2007 - December 2009)
Assistant Professor of Clinical Investigation @ (July 2004 - July 2007)
Pediatric Hematology and Oncology Fellow @ (January 2001 - January 2004)
Resident @ (January 1999 - January 2001)
Sergey Yurasov Skills
Oncology
Drug Development
Pediatrics
Immunology
Clinical Trials
Clinical Development
Clinical Research
Cancer
Biotechnology
Hematology
Biomarkers
Drug Discovery
Pharmaceutical Industry
Teaching
Management
Microsoft Excel
Business Development
Research
Leadership
Microsoft Office
Healthcare Management
Strategic Planning
Sergey Yurasov Summary
Sergey Yurasov, based in San Francisco, CA, US, is currently a Chief Medical Officer at Black Diamond Therapeutics. Sergey Yurasov brings experience from previous roles at Nuvation Bio, Immune Design (acquired by Merck) and Clovis Oncology. With a robust skill set that includes Oncology, Drug Development, Pediatrics, Immunology, Clinical Trials and more. Sergey Yurasov has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Sergey Yurasov?
Find contact details for 700 million professionals.